No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Instruments & Supplies
Shanghai Conant Optical Co., Ltd. specializes in the global production and sale of resin eyeglass lenses. The company's extensive reach covers continents such as Asia, Europe, North and South America, Africa, and Oceania, in addition to its home market of China. It supplies a diverse range of optical solutions, including both standardized products and custom-tailored lenses. Its primary clientele consists of brand owners within the spectacle lens industry and various ophthalmic optics enterprises. The firm was established in 2011 and operates from its headquarters in Shanghai, China.
www.conantoptical.comNo one on the platform currently holds 2276.HK.
No tracked institution reports a position in 2276.HK as of their last filing.
No one on the platform has traded 2276.HK yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 22.4% | 22.9% | — | — | — | |
| Rev. Growth % | 6.1% | 14.9% | ||||
| Profit Margin % | 25.5% | 18.9% | ||||
| Free Cash Flow Margin % | 11.1% | 9.8% | ||||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $2.6B | +10.2% | $1.46 | $1.38–$1.55 | — | 7 |
| 2027 | $3.2B | +22.7% | $1.94 | $1.72–$2.55 | — | 7 |
| 2028 | $3.9B | +20.5% | $2.45 | $2.25–$2.69 | — | 5 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 2276.HKShanghai Conant Optical Co., Ltd. | $40.78 | -1.02% | $19.7B | — |
| 0013.HKHUTCHMED (China) Limited | $21.58 | +0.84% | $18.8B | — |
| 0853.HKMicroPort Scientific Corp. | $6.08 | +0.00% | $11.6B | — |
| 1066.HKShandong Weigao Group Medical Polymer Company Limited | $3.17 | +0.00% | $14.1B | — |
| 3933.HKThe United Laboratories International Holdings Limited |
| $7.90 |
| -2.77% |
| $15.6B |
| — |
| 6127.HKJoinn Laboratories(China)Co.,Ltd. | $22.10 | -1.07% | $30.3B | — |
| 6699.HKAngelalign Technology Inc. | $88.25 | +0.06% | $15.2B | — |
Source: Financial Modeling Prep · peers by sector/industry